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Background: Antibiotics is are a group of compounds that could can inhibit bacterial growth 
(bacteriostatic) or cause of death bacterial (bactericidal). Bacterial organisme resistance occurs due 
to inappropriate administration of antibiotic doses and mis of diagnosis by health workers. Bacteria 
that was are resistant to penicillin, cephalosforin and aztreonam generally have has an enzyme 
released to defend themselves, this enzyme was is called Extended Spectrum Beta Lactamase 
(ESBL).  
Method: The purpose of this This study aims to determine the number of gram-negative bacteria 
that produce Extended Spectrum Beta Lactamase (ESBL) which is determinant examined from 
samples that are were cultured in the microbiology section in the laboratory of RSUD Prof. 
DR.W.Z. Johannes Kupang from 2016 to 2018. Secondary data were taken, processed and 
presented in descriptive form.  
Result::The Bacteria Extended Spectrum Beta Lactamase (ESBL) was the most find found is 104 
(50.9%) Klebsiella pneumoniae bacteria, followed by 56 (29.78%) Escherichia coli bacteria, and 
Enterobacteriaceae (3.61%). ESBL group bacteria mostly came from the Neonatal Intensive Care 
Unit (NICU) room as many as 26, ESBL group bacteria were mostly found in pus samples as many 
as 33 (19.41%).  





 INTRODUCTION  
Antibiotics work through four main mechanisms, namely by influencing cell walls, disrupting cell 
membrane function, inhibiting protein synthesis and inhibiting nucleic acid synthesis18. These 
bacteria had have the defense power to avoid antibiotics by mutating the active side, formed 
forming trans membrane proteins (protein efflux) and encoding plasmid genes that are resistant 
for antibiotics8.  
Actually as the clinically Clinically, the hydrolysis of beta lactamase antibiotics is the most 
frequent mechanism underlying the occurrence of resistance to beta lactam antibiotics in gram 
negative bacteria3.  
 
The beta lactamase enzyme was first identified in the Escherichia coli bacterium which was given 
the name ESBL type TEM or TEM. Later exploration proved that TEM was encoded by an gene 
resistant for antibiotic which located in the plasmid. Besides Escherichia coli, TEM enzymes are 
also currently found in Pseudomonas aeruginosa, Haemophilus influenzae and Neisseria 
gonorrhoeae14.  
 
Therapy of bacterial infection that produces beta lactamase has been using cephalosporin and 
aztreonam antibiotics which are also included as a beta lactam antibiotic group 4. In fact, this drug 
cannot kill of bacteria, because the bacteria can develop resistance spectrum until imun to 
penicillin, cephalosporin and aztreonam so that this enzyme is called Extended Spectrum Beta 
Lactamase (ESBL)18. The ability of ESBL strain bacteria to hydrolyze beta lactam antibiotics is 
widely caused by a number of mutations in the TEM and SHV genes 5,6,7. These mutations 
generally affect the active site area of the enzyme so that the activity of the enzyme increases14,2. 
 
 Various Gram-negative bacteria, especially the family Enterobacteriaceae, including causes of 
nosocomial infections or known as Healthcare-Associated Infection (HAIs). In Indonesia, the 
incidence of HAIs is quite high at 6-16% with an average of 9.8% in 20109.  
Several studies in America and Europe show that the prevalence of ESBL-producing bacteria 
reaches 60% of the existing clinical isolation 13. So that treatment and selection of antibiotics 
becomes very difficult if there is a new type that is resistant to ESBL13.  
 
In Indonesia the prevalence of infection by ESBL-producing bacteria reaches 65%9. In Prof. 
Hospital DR. W. Z. Johannes Kupang, East Nusa Tenggara Province has not measured the number 
of gram-negative bacteria that produce ESBL even though paramedics has carried out the 
examination of bacterial culture, resistance and sensitivity to antibiotics in clinical microbiological 
specimens. From the description above encourages the author to conduct research on the 
Prevalence of Negative Gram Bacteria Strain Extended Spectrum Beta Lactamase (ESBL) in Prof. 
DR. Hospital. W. Z. Johannes Kupang from 2016-2018. The results of this study can be used as a 
reference for therapy as well as data to monitor germ resistance and sensitivity patterns, as well as 




This research was conducted by taking and processing secondary data at the Clinical Microbiology 
Laboratory at Prof. DR. W.Z. Johannes Kupang about the number of Gram negative bacteria ESBL 
strains from 2016 to 2018 from taken cultures of various specimens. Did you have ethical 
cleareance ? informed concern ?  
RESULTS AND DISCUSSION  
Secondary data on the number of ESBL bacteria in 2016 - 2018 can be seen in table 1 below.  






Mention the name of the bacteria 
In the chart above shows that most ESBL-producing bacteria in 2016 to 2018 were Klebsiella 
pneumoniae with a total sample of 204 with a total positive ESBL of 104 (50.9%), followed by 
Escherichia coli with a total sample of 188 with a total positive of ESBL 56 (29.78%), and 
Enterobacteriaceae bacteriaceasss bacteria with a total sample of 83 samples with a total positive 
ESBL of 3 (3.61%). So the total ESBL positive is 163. Table 2 Bar chart of the number of ESBL 
bacteria by room / location in 2016 – 2018  
 
Cara penulisan nama ilmiah bakteri;  
From the diagram above it can be seen that the Gram-negative bacterial strain ESBL for the room 
/location is most commonly found in the Neonatal Intensive Care Unit (NICU) room with the 
bacteria Klebsiella pneumoniae (26), and followed in room 3 for Female / Cempaka (9), then in 
room 3 male / Kelimutu (8). Escherichia coli was found mostly in room 3 Female / Cempaka (7), 
then in the Neonatal Intensive Care Unit (NICU) room (3) and room 2 Female / orchids (3) and 
room 3 men / Kelimutu with total bacteria (3) . Of the total bacteria, there was not this is not 
included in the total than the Enterobacteriaceae bacteria because the the complit number was 
totally total number is very small and is not present in one location / room.  
With the discovery of the Gram-negative bacteria Enterobacteriaceae family especially in the 
NICU room, this is the same as previous research that Gram-negative bacteria, especially the 
Enterobacteriaceae family are the main bacteria that cause nosocomial infections or what is now 
known as Healthcare-Associated Infection (HAIs)15. The main problem of The cause of HAIs 
often occurs especially in infants receiving treatment at the NICU1. With the discovery of 
Klebsiella pneumoniae in the NICU ward / ward, this is the same as the previous research that 
found that one bacterial Klebsiella sp. ESBL was positive at RSUD Prof.DR.W.Z.Johannes 
Kupang in the NICU room 10.  
 
Bacterial resistance to antibiotics is increasingly widespread if the use is not done rationally, such 
as the use of antibiotics without regard to bacterial sensitivity testing15,12. Sources of transmission 
of infections that often occur in the NICU space include the use of assistive devices such as 
ventilators, infusions, intravenous catheters and urine catheters. Transmission can also occur 
directly from individuals and transmission from paramedics16,11.  
Table 3 Bar chart of the number of ESBL bacteria by type of sample / specimen in 2016 – 2018 
 
 
From the diagram above it can be seen that the ESBL-producing bacteria 2016 -2018 with a total 
positive ESBL of 152. Mention the number of ESBL in every year. For the bacteria Klebsiella 
pneumoniae were most commonly found in pus specimens with a total positive ESBL of 33 
(19.41%), in blood specimens in obtained positive ESBL of 29 (17%) and at least found in sputum 
samples/specimens with a total positive ESBL of 21 (12.35%). As for the Esherichia coli bacteria, 
the most in urine specimens with a total positive ESBL were 22 (16.66%), and the pus specimens 
with a total positive ESBL were 19 (14.39%) and the least was found in blood samples with a total 
positive ESBL as many as 8 (4.70%). While the rest for positive ESBL bacteria as many as 10 
(5.88%) were found in different samples / specimens with different types of bacteria as well as in 
Enterobacteriaceae (2) in pus specimens, Enterobacter cloacae (1) in pus specimens, Providencia 
stuartii (1), in urine specimens, Klebsiella oxytoca (3) in pus specimens, Pseudomonas aeruginosa 
(1) in pus specimens and Proteus sp (2) in pus specimens. Another recommendation you can put 
here for the institute or the hospital ? 
 
CONCLUSION  
The most isolated types of ESBL 2016-2018 were Klebsiella pneumonia with percentage (50.9%), 
Escherichia coli (29.78%), and Enterobacteriaceae (3.61%),  
Most room/location for the type of bacteria Klebsiella pneumoniae were found in the Neonatal 
Intensive Care Unit (NICU) room (26), then followed by room 3 Female / Cempaka9 and in room 
3 Male / Kelimutu8. In Escherichia coli bacteria, it is found mostly in room 3 for Female / 
Cempaka7, in the Neonatal Intensive Care Unit (NICU) room3 then in room for 2 Female / 
Orchid), room 3 for Male / Kelimutu3. 
  
The most samples for the type of bacteria Klebsiella pneumoniae with a positive ESBL percentage 
of 33(19.41%), were found in pus specimens, in blood specimens there were positive ESBLs of 
29(17%) and the least were found in sputum / sputum specimens / specimens with a total positive 
ESBL of 21(12.35%). As for the Esherichia coli bacteria, most were in urine specimens with a 
total positive ESBL of 22(16.66%), and in pus specimens with a total positive ESBL as many as 
19 (14.39%) and the least were found in blood samples with a total positive ESBL as many as 8 
(4.70%). While the remaining 10 positive ESBL bacteria were found (5.88%) in different samples 
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